Anthony Petrone
Stock Analyst at Mizuho Securities
(4.58)
# 972
Out of 4,792 analysts
661
Total ratings
53.8%
Success rate
9.2%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Reiterated: Buy | $100 → $115 | $91.62 | +25.52% | 29 | Sep 2, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $21 → $26 | $22.44 | +15.86% | 4 | Sep 2, 2026 | |
| LIVN LivaNova | Reiterated: Buy | n/a | $78.18 | - | 29 | Aug 21, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Buy | CHF 64.83 → CHF 68.88 | CHF 54.52 | +26.35% | 25 | Aug 13, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $90 → $95 | $101.06 | -6.00% | 71 | Aug 11, 2026 | |
| RMD ResMed | Reiterated: Buy | $220 → $235 | $219.58 | +7.02% | 32 | Aug 11, 2026 | |
| PLSE Pulse Biosciences | Reiterated: Buy | $30 → $45 | $54.43 | -17.33% | 6 | Aug 10, 2026 | |
| DXCM DexCom | Reiterated: Buy | $95 | $84.51 | +12.41% | 14 | Aug 4, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Buy | $55 → $65 | $68.12 | -4.58% | 20 | Aug 4, 2026 | |
| AXGN Axogen | Reiterated: Buy | $55 → $58 | $41.85 | +38.59% | 4 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $60 | $43.10 | +39.21% | 25 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $85 | $64.24 | +32.32% | 21 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $185 | $170.38 | +8.58% | 27 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $115 | $100.39 | +14.55% | 37 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $13.87 | +58.62% | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.16 | +260.58% | 1 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $17 | $9.39 | +81.04% | 34 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $71.39 | +47.08% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $86.77 | +21.01% | 30 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $525 → $400 | $360.46 | +10.97% | 18 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $8.79 | +104.78% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $140 → $145 | $132.00 | +9.85% | 23 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $20 | $18.31 | +9.23% | 8 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $85 | $54.17 | +56.91% | 39 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $27 | $23.42 | +15.29% | 31 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $3.79 | +84.70% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $5 | $4.89 | +2.25% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $4.60 | +73.91% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $125 → $115 | $103.36 | +11.26% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $58.74 | +70.24% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $159.03 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $92.44 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $78.80 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $0.9051 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $81.12 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $15.54 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $6.37 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $18 | $18.47 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.000001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.243 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 | $201.25 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $13.59 | n/a | 1 | Aug 2, 2016 |
Medtronic
Sep 2, 2026
Reiterated: Buy
Price Target: $100 → $115
Current: $91.62
Upside: +25.52%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $22.44
Upside: +15.86%
LivaNova
Aug 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $78.18
Upside: -
Alcon Inc.
Aug 13, 2026
Reiterated: Buy
Price Target: CHF 64.83 → CHF 68.88
Current: CHF 54.52
Upside: +26.35%
Haemonetics
Aug 11, 2026
Reiterated: Buy
Price Target: $90 → $95
Current: $101.06
Upside: -6.00%
ResMed
Aug 11, 2026
Reiterated: Buy
Price Target: $220 → $235
Current: $219.58
Upside: +7.02%
Pulse Biosciences
Aug 10, 2026
Reiterated: Buy
Price Target: $30 → $45
Current: $54.43
Upside: -17.33%
DexCom
Aug 4, 2026
Reiterated: Buy
Price Target: $95
Current: $84.51
Upside: +12.41%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Buy
Price Target: $55 → $65
Current: $68.12
Upside: -4.58%
Axogen
Jul 31, 2026
Reiterated: Buy
Price Target: $55 → $58
Current: $41.85
Upside: +38.59%
Jul 31, 2026
Reiterated: Buy
Price Target: $70 → $60
Current: $43.10
Upside: +39.21%
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $85
Current: $64.24
Upside: +32.32%
Jul 31, 2026
Reiterated: Buy
Price Target: $160 → $185
Current: $170.38
Upside: +8.58%
Jul 29, 2026
Reiterated: Buy
Price Target: $120 → $115
Current: $100.39
Upside: +14.55%
Jul 28, 2026
Reiterated: Buy
Price Target: $22
Current: $13.87
Upside: +58.62%
Jul 17, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $4.16
Upside: +260.58%
Jul 15, 2026
Reiterated: Buy
Price Target: $20 → $17
Current: $9.39
Upside: +81.04%
Jul 15, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $71.39
Upside: +47.08%
Jul 15, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $86.77
Upside: +21.01%
Jul 15, 2026
Reiterated: Hold
Price Target: $525 → $400
Current: $360.46
Upside: +10.97%
Jul 15, 2026
Reiterated: Buy
Price Target: $20 → $18
Current: $8.79
Upside: +104.78%
Jul 15, 2026
Reiterated: Hold
Price Target: $140 → $145
Current: $132.00
Upside: +9.85%
Jul 15, 2026
Reiterated: Hold
Price Target: $24 → $20
Current: $18.31
Upside: +9.23%
Jun 3, 2026
Reiterated: Buy
Price Target: $100 → $85
Current: $54.17
Upside: +56.91%
May 14, 2026
Reiterated: Hold
Price Target: $22 → $27
Current: $23.42
Upside: +15.29%
May 7, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $3.79
Upside: +84.70%
May 6, 2026
Reiterated: Hold
Price Target: $12 → $5
Current: $4.89
Upside: +2.25%
Apr 30, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $4.60
Upside: +73.91%
Apr 20, 2026
Reiterated: Hold
Price Target: $125 → $115
Current: $103.36
Upside: +11.26%
Apr 13, 2026
Reiterated: Buy
Price Target: $100
Current: $58.74
Upside: +70.24%
Jun 13, 2025
Reiterated: Buy
Price Target: $65
Current: $159.03
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $175
Current: $92.44
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $78.80
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $0.9051
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $81.12
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $15.54
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $6.37
Upside: n/a
Aug 13, 2020
Reiterated: Hold
Price Target: $25 → $18
Current: $18.47
Upside: n/a
Dec 3, 2019
Reiterated: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $0.243
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Reiterated: Buy
Price Target: $93
Current: $201.25
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $13.59
Upside: n/a